| Preferred Name |
alosetron |
| Synonyms |
alosetron monohydrochloride |
| ID |
http://purl.bioontology.org/ontology/MESH/C090840 |
| altLabel |
alosetron monohydrochloride 1H-pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)- GR68755 alosetron hydrochloride 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride Lotronex GR 68755 |
| cui |
C0291772 C0291771 C0876076 C0964961 |
| HM |
D002243 |
| Inverse of RB |
13Z9HTH115 2F5R1A46YW 0 |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19950109 |
| MeSH Frequency |
213 |
| MMR |
20161221 |
| notation |
C090840 |
| PA |
D005765 D012702 |
| prefLabel |
alosetron |
| RR |
2F5R1A46YW 122852-42-0 (alosetron) |
| SC |
1 |
| SRC |
Aliment Pharmacol Ther 1994 Aug;8(4):403-7 |
| TERMUI |
T270030 T433510 T356799 T270029 T270028 T433509 T433511 |
| TH |
FDA SRS (2015) US FDA SRS (2013) USAN (19XX) NLM (2001) MX PR NLM (1995) INN (19XX) |
| tui |
T109 T121 |